Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Cost considerations as potential barriers to cancer treatment
Jeffrey J. Guidry
, Lu Ann Aday
, Dong Zhang
, Rodger J. Winn
Sealy Center on Aging
Research output
:
Contribution to journal
›
Article
›
peer-review
68
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cost considerations as potential barriers to cancer treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Treatment
100%
Cost Consideration
100%
Potential Barrier
100%
Cancer Patients
66%
Hispanic
55%
Insurance Coverage
55%
Texas
44%
Direct Costs
22%
Treatment Facilities
22%
People of Color
22%
Indirect Costs
22%
Barriers to Treatment
22%
Lodging
22%
Out-of-pocket Expenditure
22%
Cancer Survivors
11%
University of Texas
11%
White People
11%
Colon
11%
Hospitalization
11%
Health Care Costs
11%
Nonclinical
11%
Diagnostic Test
11%
MD Anderson Cancer Center
11%
Breast
11%
Prostate
11%
Cancer Types
11%
Lymphoma
11%
Ethnic Differences
11%
Financial Factors
11%
Treatment-related
11%
Insurance Costs
11%
Additional Service
11%
Response Rate
11%
Differential Response
11%
Sampling Frame
11%
American Cancer Society
11%
Barriers to Care
11%
Transportation Cost
11%
% Response
11%
Weight Adjustment
11%
Perceived Barriers
11%
Sampling Rate
11%
Hospital Programs
11%
Workdays Lost
11%
Adult Cancer Patients
11%
Financial Considerations
11%
Differential Sampling
11%
Advocacy Groups
11%
Diagnostic Stages
11%
Overcoming Barriers
11%
Insurance Premium
11%
Treatment Stage
11%
Mail Questionnaires
11%
Cost Barriers
11%
Community Oncology
11%
Oncological Networks
11%
Medicine and Dentistry
Malignant Neoplasm
100%
Cancer Therapy
100%
Health Care Cost
100%
Potential Barrier
100%
Cancer Treatment
18%
Prevalence
9%
Colon
9%
Oncology
9%
Cross Sectional Study
9%
Case Management
9%
Diagnostic Test
9%
Ethnic Difference
9%
Engineering
Related Cost
100%
Direct Cost
100%
Indirect Cost
100%
Individual Patient
50%
Social Sciences
Texas
100%
Insurance Coverage
100%
Transport
40%
People of Color
40%
Advocacy
20%
Case Management
20%
Prevalence
20%
Nursing and Health Professions
Malignant Neoplasm
100%
Cancer Therapy
100%
Cancer Center
10%
Prevalence
10%
Case Management
10%
Diagnostic Test
10%
Cross-Sectional Survey
10%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Prevalence
5%
Cross Sectional Study
5%